For these individuals a pharmaceutical product could be of help and indeed numerous agents currently under assessment for the treatment of sarcopenia, including testosterone, dehydroepiandrosterone, oestrogen, growth hormone, ghrelin, angiotensin converting enzyme inhibitor, eicosapentaenoic acid and ryanodine receptor modulators [6]. The gene discussed is GH1; the disease is sarcopenia.